share_log

iBio Inc | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)

iBio Inc | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)

iBio Inc | SC 13G/A：超過5%持股股東披露文件(修正)
SEC announcement ·  04/10 05:26
牛牛AI助理已提取核心訊息
Opaleye Management Inc. has filed an amended Schedule 13G/A with the United States Securities and Exchange Commission on March 28, 2024, indicating a significant ownership stake in iBio Inc. The filing reveals that Opaleye Management holds 650,000 shares of iBio Inc.'s common stock, which represents 7.63% of the company's total shares issued and outstanding as of April 1, 2024. This ownership level is based on 8,515,226 shares of common stock outstanding, as reported by iBio Inc. in its registration statement. The shares are reported to be held with shared voting and dispositive power, and the filing asserts that the acquisition of these shares is not for the purpose of changing or influencing the control of iBio Inc.
Opaleye Management Inc. has filed an amended Schedule 13G/A with the United States Securities and Exchange Commission on March 28, 2024, indicating a significant ownership stake in iBio Inc. The filing reveals that Opaleye Management holds 650,000 shares of iBio Inc.'s common stock, which represents 7.63% of the company's total shares issued and outstanding as of April 1, 2024. This ownership level is based on 8,515,226 shares of common stock outstanding, as reported by iBio Inc. in its registration statement. The shares are reported to be held with shared voting and dispositive power, and the filing asserts that the acquisition of these shares is not for the purpose of changing or influencing the control of iBio Inc.
Opaleye Management Inc.已於2024年3月28日向美國證券交易委員會提交了經修訂的附表13G/A，表示擁有iBio Inc.的大量所有權。該文件顯示，Opaleye Management持有iBio Inc.的65萬股股份。s 普通股，佔截至2024年4月1日公司已發行和流通股票總數的7.63％。根據iBio Inc.在其註冊聲明中報告的8,515,226股已發行普通股，該所有權水平基於8,515,226股。據報道，這些股票是以共同的投票權和處置權持有的，該文件斷言，收購這些股份的目的不是爲了改變或影響iBio Inc的控制權。
Opaleye Management Inc.已於2024年3月28日向美國證券交易委員會提交了經修訂的附表13G/A，表示擁有iBio Inc.的大量所有權。該文件顯示，Opaleye Management持有iBio Inc.的65萬股股份。s 普通股，佔截至2024年4月1日公司已發行和流通股票總數的7.63％。根據iBio Inc.在其註冊聲明中報告的8,515,226股已發行普通股，該所有權水平基於8,515,226股。據報道，這些股票是以共同的投票權和處置權持有的，該文件斷言，收購這些股份的目的不是爲了改變或影響iBio Inc的控制權。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。